Trial Information
Inclusion Criteria:
all infants born in Qidong between September 1983 and November 1990
Exclusion Criteria:
-
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Principal Investigator
Zongtang Sun, MD
Investigator Role:
Study Director
Investigator Affiliation:
Cancer Institute, Chinese Academy of Medical Sciences
Authority:
China: Ministry of Health
Study ID:
Qidong-HBV-Study
NCT ID:
NCT00222664
Start Date:
September 1983
Completion Date:
December 2004
Related Keywords:
- Hepatitis B
- Liver Neoplasms
- Liver Diseases
- hepatitis B
- hepatocellular carcinoma
- prevention
- vaccination
- Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- Liver Diseases
- Liver Neoplasms